NCT04979091View on ClinicalTrials.gov

Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

March 8, 2020

Primary Completion Date

February 26, 2021

Study Completion Date

May 31, 2021

Conditions

Covid19Critical Illness

Interventions

DIAGNOSTIC_TEST

Sex Hormones

A panel of 13 hormones was measured in plasma samples of COVID-19 patients (total testosterone, free testosterone, dihydrotestosterone, androstenedione, 17-β-estradiol, estrone, sex hormone-binding globulin, thyroid-stimulating hormone, free triiodothyronine (T3), free thyroxine (T4), luteinizing hormone, follicle-stimulating hormone and cortisol).

Trial Locations (1)

20246

University Medical Center, Hamburg

All Listed Sponsors

collaborator

Federal Ministry of Health, Germany

OTHER_GOV

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT04979091 - Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients | Biotech Hunter | Biotech Hunter